On the other hand, men heterozygous for APOE4 exhibit essentially no increase in AD risk, whereas those with two copies of APOE4 allele carry similar or greater risk for MCI and AD than homozygous women [5, 13, 15, 16]. This evidence concerns the gene APOE and Alzheimer disease.